11.11.2009 • News

Arch Chemicals Q2 Profit Slips

Arch Chemicals said that second-quarter profit fell as lower volumes and unfavourable foreign exchange rates offset higher pricing and the favorable impact of the Advantis acquisition. Net earnings declined to $30.9 million, or $1.23 per share, from $33.2 million, or $1.33 per share, a year earlier, the Norwalk, Connecticut-based company said. Revenue fell to $414.2 million from $469.6 million.

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.